Your browser doesn't support javascript.
loading
The surgical and clinicopathological characteristics of primary mucinous ovarian cancer: a single institution 30-year retrospective analysis.
Aytekin, Okan; Yüksel, Dilek; Oktar, Okan; Çakir, Caner; Kimyon Cömert, Günsu; Korkmaz, Vakkas; Engin-Üstün, Yaprak; Turan, Taner.
Afiliação
  • Aytekin O; Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara City Hospital, Ankara, Turkey.
  • Yüksel D; Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanim Women's Health Training and Research Hospital, Ankara, Turkey.
  • Oktar O; Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanim Women's Health Training and Research Hospital, Ankara, Turkey.
  • Çakir C; Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanim Women's Health Training and Research Hospital, Ankara, Turkey.
  • Kimyon Cömert G; Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanim Women's Health Training and Research Hospital, Ankara, Turkey.
  • Korkmaz V; Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanim Women's Health Training and Research Hospital, Ankara, Turkey.
  • Engin-Üstün Y; Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanim Women's Health and Research Center, Ankara, Turkey.
  • Turan T; Clinic of Gynecologic Oncology, University of Health Sciences Turkey, Ankara Etlik Zübeyde Hanim Women's Health Training and Research Hospital, Ankara, Turkey.
J Turk Ger Gynecol Assoc ; 24(4): 252-260, 2023 Dec 06.
Article em En | MEDLINE | ID: mdl-38054417
Objective: To evaluate the clinicopathological characteristics of primary mucinous ovarian carcinoma (MOC) and define oncologic outcomes. Material and Methods: This retrospective study reviewed patients diagnosed with primary MOC at a single institution and underwent primary treatment between 1990 and 2019. The clinicopathological factors affecting oncological outcomes and treatment response were evaluated. The Kaplan-Meier method was used to evaluate survival outcomes. Survival curves were compared using the log-rank test. Results: The cohort's (n=92) median (range) age was 48 (15-82) years. Seventy-five (81.5%) patients were in the International Federation of Gynecology and Obstetrics stage I-II. Forty patients received platinum-based adjuvant chemotherapy. The 5-year progression-free survival was 98% in stage I-II and 17% for stage III-IV (p<0.001). In multivariate analysis, the only independent risk factor for disease failure was stage (hazard ratio: 6.838, 95% confidence interval: 1,358-34,415; p=0.020). Conclusion: Advanced stage was an independent poor prognostic factor for recurrence in patient with MOC.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article